Production and Analysis of Biological Properties of Recombinant Human Apolipoprotein A-I

Verfasser / Beitragende:
[A. Ryabchenko, M. Kotova, N. Tverdohleb, R. Knyazev, L. Polyakov]
Ort, Verlag, Jahr:
2015
Enthalten in:
Bulletin of Experimental Biology and Medicine, 160/1(2015-11-01), 129-133
Format:
Artikel (online)
ID: 605536864
LEADER caa a22 4500
001 605536864
003 CHVBK
005 20210128100854.0
007 cr unu---uuuuu
008 210128e20151101xx s 000 0 eng
024 7 0 |a 10.1007/s10517-015-3113-4  |2 doi 
035 |a (NATIONALLICENCE)springer-10.1007/s10517-015-3113-4 
245 0 0 |a Production and Analysis of Biological Properties of Recombinant Human Apolipoprotein A-I  |h [Elektronische Daten]  |c [A. Ryabchenko, M. Kotova, N. Tverdohleb, R. Knyazev, L. Polyakov] 
520 3 |a Production of recombinant human apolipoprotein A-I (apoA-I) in E. coli cells is described and its biological properties are compared with those of natural protein. Recombinant apoA-I was isolated as a chimeric polypeptide and then processed to a mature form apoA-I (rapo-I). We studied the ability of the resulting protein to penetrate into hepatocyte nuclei and regulate the rate of DNA biosynthesis in complex with estriol. Penetration of rapoA-I conjugated with FITC into hepatocyte nuclei was demonstrated. rapoA-I-estriol and apoA-I-estriol complexes induced similar increase in DNA biosynthesis rate in isolated hepatocytes, which confi rms functional similarity of the obtained recombinant mature protein (rapoA-I) and native human apoA-I. 
540 |a Springer Science+Business Media New York, 2015 
690 7 |a recombinant apoA-I protein  |2 nationallicence 
690 7 |a E. coli  |2 nationallicence 
690 7 |a hepatocytes  |2 nationallicence 
690 7 |a estriol  |2 nationallicence 
690 7 |a DNA biosynthesis  |2 nationallicence 
700 1 |a Ryabchenko  |D A.  |u Laboratory of Medical Biotechnology, Research Institute of Biochemistry, Siberian Division of the Russian Academy of Medical Sciences, Novosibirsk, Russia  |4 aut 
700 1 |a Kotova  |D M.  |u Laboratory of Medical Biotechnology, Research Institute of Biochemistry, Siberian Division of the Russian Academy of Medical Sciences, Novosibirsk, Russia  |4 aut 
700 1 |a Tverdohleb  |D N.  |u Laboratory of Medical Biotechnology, Research Institute of Biochemistry, Siberian Division of the Russian Academy of Medical Sciences, Novosibirsk, Russia  |4 aut 
700 1 |a Knyazev  |D R.  |u Laboratory of Medical Biotechnology, Research Institute of Biochemistry, Siberian Division of the Russian Academy of Medical Sciences, Novosibirsk, Russia  |4 aut 
700 1 |a Polyakov  |D L.  |u Laboratory of Medical Biotechnology, Research Institute of Biochemistry, Siberian Division of the Russian Academy of Medical Sciences, Novosibirsk, Russia  |4 aut 
773 0 |t Bulletin of Experimental Biology and Medicine  |d Springer US; http://www.springer-ny.com  |g 160/1(2015-11-01), 129-133  |x 0007-4888  |q 160:1<129  |1 2015  |2 160  |o 10517 
856 4 0 |u https://doi.org/10.1007/s10517-015-3113-4  |q text/html  |z Onlinezugriff via DOI 
898 |a BK010053  |b XK010053  |c XK010000 
900 7 |a Metadata rights reserved  |b Springer special CC-BY-NC licence  |2 nationallicence 
908 |D 1  |a research-article  |2 jats 
949 |B NATIONALLICENCE  |F NATIONALLICENCE  |b NL-springer 
950 |B NATIONALLICENCE  |P 856  |E 40  |u https://doi.org/10.1007/s10517-015-3113-4  |q text/html  |z Onlinezugriff via DOI 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Ryabchenko  |D A.  |u Laboratory of Medical Biotechnology, Research Institute of Biochemistry, Siberian Division of the Russian Academy of Medical Sciences, Novosibirsk, Russia  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Kotova  |D M.  |u Laboratory of Medical Biotechnology, Research Institute of Biochemistry, Siberian Division of the Russian Academy of Medical Sciences, Novosibirsk, Russia  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Tverdohleb  |D N.  |u Laboratory of Medical Biotechnology, Research Institute of Biochemistry, Siberian Division of the Russian Academy of Medical Sciences, Novosibirsk, Russia  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Knyazev  |D R.  |u Laboratory of Medical Biotechnology, Research Institute of Biochemistry, Siberian Division of the Russian Academy of Medical Sciences, Novosibirsk, Russia  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Polyakov  |D L.  |u Laboratory of Medical Biotechnology, Research Institute of Biochemistry, Siberian Division of the Russian Academy of Medical Sciences, Novosibirsk, Russia  |4 aut 
950 |B NATIONALLICENCE  |P 773  |E 0-  |t Bulletin of Experimental Biology and Medicine  |d Springer US; http://www.springer-ny.com  |g 160/1(2015-11-01), 129-133  |x 0007-4888  |q 160:1<129  |1 2015  |2 160  |o 10517